Pharmacologic Management of Portal Hypertension

被引:24
作者
Bunchorntavakul, Chalermrat [1 ,2 ]
Reddy, K. Rajender [2 ]
机构
[1] Rangsit Univ, Rajavithi Hosp, Div Gastroenterol & Hepatol, Dept Med, Rajavithi Rd, Bangkok 10400, Thailand
[2] Univ Penn, Dept Med, Div Gastroenterol & Hepatol, 2 Dulles,3400 Spruce St, Philadelphia, PA 19104 USA
关键词
Portal hypertension; Variceal hemorrhage; Terlipressin; Somatostatin; Propranolol; Carvedilol; VARICEAL BAND LIGATION; INTRAHEPATIC ENDOTHELIAL DYSFUNCTION; RANDOMIZED CONTROLLED-TRIAL; NONSELECTIVE BETA-BLOCKERS; TERLIPRESSIN PLUS ALBUMIN; AGONIST OBETICHOLIC ACID; CIRRHOTIC RAT LIVERS; HEPATORENAL-SYNDROME; DOUBLE-BLIND; SYSTEMIC HEMODYNAMICS;
D O I
10.1016/j.cld.2019.06.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Terlipressin, somatostatin, or octreotide are recommended as pharmacologic treatment of acute variceal hemorrhage. Nonselective beta-blockers decrease the risk of variceal hemorrhage and hepatic decompensation, particularly in those 30% to 40% of patients with good hemodynamic response. Carvedilol, statins, and anticoagulants are promising agents in the management of portal hypertension. Recent advances in the pharmacologic treatment of portal hypertension have mainly focused on modifying an increased intrahepatic resistance through nitric oxide and/or modulation of vasoactive substances. Several novel pharmacologic agents for portal hypertension are being evaluated in humans.
引用
收藏
页码:713 / +
页数:25
相关论文
共 141 条
[1]   Somatostatin and analogues in portal hypertension [J].
Abraldes, JG ;
Bosch, J .
HEPATOLOGY, 2002, 35 (06) :1305-1312
[2]   Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats [J].
Abraldes, Juan G. ;
Rodriguez-Vilarrupla, Aina ;
Graupera, Mariona ;
Zafra, Carmen ;
Garcia-Caldero, Hector ;
Garcia-Pagan, Juan Carlos ;
Bosch, Jaime .
JOURNAL OF HEPATOLOGY, 2007, 46 (06) :1040-1046
[3]   Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis [J].
Abraldes, Juan G. ;
Villanueva, Candid ;
Aracil, Carles ;
Turnes, Juan ;
Hernandez-Guerra, Manuel ;
Genesca, Joan ;
Rodriguez, Manuel ;
Castellote, Jose ;
Carlos Garcia-Pagan, Juan ;
Torres, Ferran ;
Luis Calleja, Jose ;
Albillos, Agustin ;
Bosch, Jaime .
GASTROENTEROLOGY, 2016, 150 (05) :1160-+
[4]  
ALBILLOS A, 1994, HEPATOLOGY, V20, P611, DOI 10.1016/0270-9139(94)90095-7
[5]   CONTINUOUS PRAZOSIN ADMINISTRATION IN CIRRHOTIC-PATIENTS - EFFECTS ON PORTAL HEMODYNAMICS AND ON LIVER AND RENAL-FUNCTION [J].
ALBILLOS, A ;
LLEDO, JL ;
ROSSI, I ;
PEREZPARAMO, M ;
TABUENCA, MJ ;
BANARES, R ;
IBORRA, J ;
GARRIDO, A ;
ESCARTIN, P ;
BOSCH, J .
GASTROENTEROLOGY, 1995, 109 (04) :1257-1265
[6]   OCTREOTIDE PREVENTS POSTPRANDIAL SPLANCHNIC HYPEREMIA IN PATIENTS WITH PORTAL-HYPERTENSION [J].
ALBILLOS, A ;
ROSSI, I ;
IBORRA, J ;
LLEDO, JL ;
CALLEJA, JL ;
BARRIOS, C ;
GARCIA, P ;
ESCARTIN, P .
JOURNAL OF HEPATOLOGY, 1994, 21 (01) :88-94
[7]   Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome [J].
Allegretti, Andrew S. ;
Israelsen, Mads ;
Krag, Aleksander ;
Jovani, Manol ;
Goldin, Alison H. ;
Schulman, Allison R. ;
Winter, Rachel W. ;
Gluud, Lise Lotte .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (06)
[8]   Pharmacologic prevention of variceal bleeding and rebleeding [J].
Baiges, Anna ;
Hernandez-Gea, Virginia ;
Bosch, Jaime .
HEPATOLOGY INTERNATIONAL, 2018, 12 :S68-S80
[9]   Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: A randomized comparison [J].
Baik, SK ;
Jeong, PH ;
Ji, SW ;
Yoo, BS ;
Kim, HS ;
Lee, DK ;
Kwon, SO ;
Kim, YJ ;
Park, JW ;
Chang, SJ ;
Lee, SS .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03) :631-635
[10]   Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis [J].
Bañares, R ;
Moitinho, E ;
Piqueras, B ;
Casado, M ;
García-Pagán, JC ;
de Diego, A ;
Bosch, J .
HEPATOLOGY, 1999, 30 (01) :79-83